Dolby Laboratories, Inc. vs Twist Bioscience Corp — how do they compare? Dolby Laboratories, Inc. trades at $48.49 (market cap $4.67B), while Twist Bioscience Corp trades at $92.62 (market cap $5.63B). The key difference: Twist Bioscience Corp is the larger of the two by market cap, and Dolby Laboratories, Inc. pays a 2.86% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| DLB | TWST | |
|---|---|---|
Market Cap | $4.67B | $5.63B |
Sector | Industrials | Health |
52-Week High | $76.79 | $102.88 |
52-Week Low | $48.51 | $24.16 |
Enterprise Value | $4.12B | $5.55B |
Dividend Yield | 2.86% | — |
Trailing returns across standard periods
Latest headlines on both assets
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →